Pimozide Tablet Market

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.

Pimozide Tablet Market contains market size and forecasts of Pimozide Tablet in global, including the following market information:

• Global Pimozide Tablet Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Pimozide Tablet Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Pimozide Tablet companies in 2021 (%)

The global Pimozide Tablet market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

1Mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pimozide Tablet include Teva, Par Pharmaceutical, Johnson & Johnson, Eumedica, Pharmascience, Domina Pharmaceuticals and Aa Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pimozide Tablet manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pimozide Tablet Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pimozide Tablet Market Segment Percentages, by Type, 2021 (%)

• 1Mg
• 2Mg
• 4Mg

Global Pimozide Tablet Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pimozide Tablet Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Drugstores
• Others

Global Pimozide Tablet Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pimozide Tablet Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Pimozide Tablet revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Pimozide Tablet revenues share in global market, 2021 (%)
• Key companies Pimozide Tablet sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Pimozide Tablet sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Teva
• Par Pharmaceutical
• Johnson & Johnson
• Eumedica
• Pharmascience
• Domina Pharmaceuticals
• Aa Pharma